Patents matching “pad”

WO 2026075941

DÉRIVÉS DE PYRIDAZINONE EN TANT QU'INHIBITEURS DE PAD4

BRISTOL MYERS SQUIBB CO [US] · Granted Apr 9, 2026 · Expires Apr 4, 2046

WO 2025221754

UPADACITINIB DESTINÉ À ÊTRE UTILISÉ DANS LE TRAITEMENT DE L'ARTÉRITE À CELLULES GÉANTES

ABBVIE INC [US] · Granted Oct 23, 2025 · Expires Oct 18, 2045

US 2024398790

TREATING SPONDYLOARTHRITIC CONDITIONS WITH UPADACITINIB

ABBVIE INC [US] · Granted Dec 5, 2024 · Expires Nov 30, 2044

US 2024390367

METHODS OF TREATING VITILIGO WITH UPADACITINIB

ABBVIE INC [US] · Granted Nov 28, 2024 · Expires Nov 23, 2044

US 9346759

Polymorphic crystal forms of 5-(2-{[6-(2,2-difluoro-2-phenylethoxy)hexyl]amino}-1-(R)-hydroxyethyl)-8-hydroxyquinolin-2(1H)-one, heminapadisytlate as agonist of the β2 adrenergic receptor

Almirall, S.A. · Granted May 24, 2016 · Expires May 19, 2036

US 2012255544

BEPOTASTINE COMPOSITIONS

PADILLA ANGEL [US] · Granted Oct 11, 2012 · Expires Oct 6, 2032

US 8283342

Napadisylate salt of 5-(2-{[6-(2,2-difluoro-2-phenylethoxy) hexyl]amino}-1-hydroxyethyl)-8-hydroxyquinolin-2(1H)-one as agonist of the β2 adrenergic receptor

Almirall, S.A. · Granted Oct 9, 2012 · Expires Oct 4, 2032